NICE says Provenge's cost was provided by the company, but is conditional on the treatment being launched and may be subject to change. NICE says any change will be reflected in the next iteration ...

Provenge already looks like the product of a bygone era. The approval of Provenge is remarkable. It represents a triumph of esotericism over the scientific method; a victory for doggedness over ...

Its prostate cancer immunotherapy vaccine Provenge initially promised great things when it was launched in the US in 2010, but its high price and competition from more convenient oral treatments ...

In April 2010, sipuleucel-T (Provenge; Dendreon), an autologous cellular immunotherapy, was approved by the US FDA for the treatment of asymptomatic or minimally symptomatic metastatic castration ...